A recent study including Zack Meisel was featured by Penn LDI for illuminating that only 1 in 3 pregnant individuals who were eligible for an evidence-based buprenorphine treatment actually received it, which contributes to maternal mortality.
Emily Seeburger and Shoshana Aronowitz published an op-ed in the Inquirer describing how the Parker administration’s approach to the opioid crisis could be strengthened by science, emphasizing that coerced treatment does not work.
Shoshana Aronowitz of the School of Nursing, Zack Meisel of the Perelman School of Medicine, and colleagues assessed the various types of prior authorization requirements for Medicaid-covered buprenorphine treatment across the 50 states, which present barriers to...
Healthcare Innovation featured the Warm Handoff project. “Our findings indicate that the screening and prompts help clinicians to recognize patients and increasingly initiate important care for them,” says Maggie Lowenstein. “There is a huge group now eligible to...
A team including Maggie Lowenstein of the Perelman School of Medicine and Shoshana Aronowitz of the School of Nursing interviewed patients and identified three facilitators for a low-barrier treatment model for opioid use disorder. Low-barrier treatment is a...
A team including Zack Meisel, Gina South, and Shoshana Aronowitz have shone a light on burnout in substance use disorder (SUD) care providers that work outside of the traditional health care setting, suggesting an improved framework is necessary to address burnout in...
A study from Kit Delgado and colleagues demonstrates that combined individual audit and peer comparison feedback can increase the frequency of low-pill opioid prescriptions in the emergency department. However, the intervention does not affect prescribing disparities...
Maggie Lowenstein was featured in two recent articles related to improved access to opioid care. The LDI blog post discusses reducing barriers to care and the WHYY article reviews the potential of over-the-counter naloxone, an overdose reversal medication.
The Injury Science Incubator returns September 19th 2:30-4:00, with a special edition! PISC Community Action Board Member Marcella Nyachogo, of Lutheran Settlement House, leads the second Community Outreach Incubator with her team to “take their...
Maggie Lowenstein sat down for a Q&A with Penn LDI’s Karl Stark to talk trends and promising efforts in opioid and substance use care. CareConnect, an opioid telehealth program on which Lowenstein collaborates with Jeanmarie Perrone, was separately featured...
